Posted June 1, 2018 by admin in articles

U.S. cancer diagnostics market to exhibit commendable growth prospects over 2017-2024, evolving technologies to characterize the industry landscape


products, analysts estimate cancer diagnostics market to tread along a lucrative growth path in the ensuing years. Companies are further embarking innovative methods such as liquid biopsies and next-generation sequencing (NGS) to address the most life-threatening form of cancers. Analysts further deem the industry to witness foreseeable growth in terms of companies launching cost-effective & accurate diagnostics methods that would satisfy growing consumer demand. For the record, some of the renowned companies partaking in global cancer diagnostics industry share include Roche, Becton, GE Healthcare, Illumina, Qiagen, Abbott Laboratories, Dickinson, and Sienna Cancer Diagnostics.


Views Count:308 views
  • Join Our Newsletter

    Signup today for free and be the first to get notified on News updates.